SoftBank-backed Lenskart, an eyewear retailer, is set to go public in India and aims to raise up to $828 million.
Eyewear retailer Lenskart Solutions Ltd. announced that its upcoming initial public offering (IPO) in Mumbai is expected to raise up to 72.8 billion Indian Rupees (approximately 828 million dollars). Currently, the Indian IPO market is experiencing a continuous rise in interest.
Eyewear retailer Lenskart Solutions Ltd. announced that it plans to raise up to 72.8 billion Indian rupees (approximately $828 million) in its upcoming initial public offering (IPO) in Mumbai. Currently, the Indian IPO market is heating up.
According to the announcement by the SoftBank Group Corp.-backed company, the IPO price range is set at 382 to 402 Indian rupees per share. Anchored investors can participate in the stock subscription on October 30, while the window for other investors will open the next day and run until November 4.
Lenskart, founded by Shark Tank India judge Peyush Bansal, is another well-known company in the recent wave of IPOs in the Indian market. Earlier this month, the Indian market saw two IPO transactions exceeding $1 billion each. The Indian IPO market is poised to set a monthly fundraising record, with 2025 potentially becoming the best year in the market's history.
The announcement states that Lenskart plans to raise 21.5 billion Indian rupees by issuing new shares, while existing shareholders will sell up to 127.6 million shares.
Data shows that Indian companies have raised nearly $16 billion through IPOs this year, compared to $21 billion for the entire previous year.
Founded in 2010, Lenskart's investors include the Abu Dhabi Investment Authority, KKR Group, and TPG Group. According to Avendus, one of the underwriters of this IPO, in 2024 Lenskart received $200 million in financing from Temasek Holdings and Fidelity Investment Research, valuing the company at $5 billion at the time. According to information disclosed in April of this year, Fidelity has increased its internal valuation of Lenskart to $6.1 billion.
Joint bookrunners for this IPO include Kotak Mahindra Capital Co., Axis Bank, Avendus Capital Pvt. Ltd., Intensive Fiscal Services Pvt. Ltd., and the Indian branches of Citigroup Inc. and Morgan Stanley.
Related Articles

The Eurozone economy is undergoing a health check! GDP and inflation data to be released soon, the road to recovery still appears bumpy.

Trading reminder: The Double Ninth Festival holiday is approaching, and the Hong Kong stock market will be closed on October 29th.

Hang Seng Hong Kong Biotechnology Index Report: China's oncology drug market is projected to achieve a compound annual growth rate of 12.4% from 2023 to 2030.
The Eurozone economy is undergoing a health check! GDP and inflation data to be released soon, the road to recovery still appears bumpy.

Trading reminder: The Double Ninth Festival holiday is approaching, and the Hong Kong stock market will be closed on October 29th.

Hang Seng Hong Kong Biotechnology Index Report: China's oncology drug market is projected to achieve a compound annual growth rate of 12.4% from 2023 to 2030.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


